14 min listen
MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease
FromVJHemOnc Podcast
MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease
FromVJHemOnc Podcast
ratings:
Length:
11 minutes
Released:
May 31, 2023
Format:
Podcast episode
Description
Therapeutic agents for patients with myelodysplastic syndromes (MDS) are currently under active investigation in clinical trials. The management of cytopenias,...
The post MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease appeared first on VJHemOnc.
The post MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease appeared first on VJHemOnc.
Released:
May 31, 2023
Format:
Podcast episode
Titles in the series (100)
Debate on the use of MRD for multiple myeloma management: The highly anticipated panel discussion on the hot topic of MRD at the Myeloma 2017 meeting in Edinburgh, UK produced... by VJHemOnc Podcast